Our Research Publications
Updated August 2024
Pagination
- Previous page
- Page 23
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Drug-induced immune haemolytic anaemias | Branch DR | 2019 | ISBT Sci Ser | View Drug-induced immune haemolytic anaemias | Researchers | Basic research |
Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department | Ramos JG, Zeller MP | 2019 | Hematology Am Soc Hematol Educ Program | View Evidence-Based Minireview: The role of IV iron in management of patients with iron-deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Label-Free Analysis of Red Blood Cell Storage Lesions Using Imaging Flow Cytometry | Pinto RN, Sebastian JA, Parsons MJ, Chang TC, Turner TR, Acker JP, Kolios MC | 2019 | Cytom Part A | View Label-Free Analysis of Red Blood Cell Storage Lesions Using Imaging Flow Cytometry | Researchers | New or improved product or process |
Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors | Al-Riyami AZ, Al-Marhoobi A, Al-Hosni S, Al Mahrooqi S, Schmidt M, O'Brien SF, Al-Khabori M | 2019 | Oman Med J | View Prevalence of Red Blood Cell Major Blood Group Antigens and Phenotypes among Omani Blood Donors | Researchers | Clinical research |
Système Rhésus : l’anticorps anti-Cw | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-Cw | Health care providers | Benchmarking and standard setting |
Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee | Cohn CS, Allen ES, Cushing MM, Dunbar NM, Friedman DF, Goel R, Harm SK, Heddle N, Hopkins CK, Klapper E, Perumbeti A, Ramsey G, Raval JS, Schwartz J, Shaz BH, Spinella PC, Pagano MB | 2019 | Transfusion | View Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee | Researchers | Clinical research |
Modulating the T Lymphocyte Immune Response via Secretome Produced miRNA: From Tolerance Induction to the Enhancement of the Anticancer Response | Scott M, Wang D, Toyofuku W, Yang X | 2019 | Cells of the Immune System | View Modulating the T Lymphocyte Immune Response via Secretome Produced miRNA: From Tolerance Induction to the Enhancement of the Anticancer Response | Researchers | Basic research |
A retrospective study of the added value of parallel titers compared with serial titers | Lin Y, Cohen R, Buckstein J, Callum J, Lieberman L | 2019 | Transfusion | View A retrospective study of the added value of parallel titers compared with serial titers | Health care providers | Clinical research |
Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Scott AN, Buchan SA, Kwong JC, Drews SJ, Simmonds KA, Svenson LW | 2019 | BMJ Open | View Using population-wide administrative and laboratory data to estimate type- and subtype-specific influenza vaccine effectiveness: a surveillance protocol | Researchers | Clinical research |
Trombocitopenia Fetal Neonatal Aloimune: Informacao ao paciente | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Trombocitopenia Fetal Neonatal Aloimune: Informacao ao paciente | Other | Other |
Heparin-induced thrombocytopenia (Chap. 26). | Warkentin TE | 2019 | Consultative Hemostasis and Thrombosis, Fourth Edition | View Heparin-induced thrombocytopenia (Chap. 26). | Other | Benchmarking and standard setting |
Bonnes pratiques en matière de transfusion de plaquettes | Romans R | 2019 | Blood.ca website | View Bonnes pratiques en matière de transfusion de plaquettes | Health care providers | Benchmarking and standard setting |
Platelet clinical best practices | Romans R | 2019 | Blood.ca website | View Platelet clinical best practices | Health care providers | Benchmarking and standard setting |
Surveillance Report 2018 | O'Brien S | 2019 | Blood.ca website | View Surveillance Report 2018 | Health care providers | Benchmarking and standard setting |
Immunotherapy: the good, the bad, the ugly, and the really ugly | Branch DR | 2019 | Transfusion | View Immunotherapy: the good, the bad, the ugly, and the really ugly | Researchers | Clinical research |
An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia | Eekels JJM, Althaus K, Bakchoul T, Kroll H, Kiefel V, Nazy I, Lee LS, Sachs U, Warkentin TE, Greinacher A | 2019 | J Thromb Haemost | View An international external quality assessment for laboratory diagnosis of heparin-induced thrombocytopenia | Researchers | New or improved product or process |
Anti-Lewis | Peng S, Meunier D | 2019 | Blood.ca website | View Anti-Lewis | Health care providers | Clinical research |
Laboratory diagnosis of heparin-induced thrombocytopenia | Warkentin TE | 2019 | Int J Lab Hematol | View Laboratory diagnosis of heparin-induced thrombocytopenia | Health care providers | Clinical research |
Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Atreya C, Glynn S, Busch M, Kleinman S, Snyder E, Rutter S, AuBuchon J, Flegel W, Reeve D, Devine D, Cohn C, Custer B, Goodrich R, Benjamin RJ, Razatos A, Cancelas J, Wagner S, Maclean M, Gelderman M, Cap A, Ness P | 2019 | Transfusion | View Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 | Researchers | New or improved product or process |
Système Rhésus : l’anticorps anti-V | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Rhésus : l’anticorps anti-V | Health care providers | Benchmarking and standard setting |
Red cell supernatant effects on endothelial cell function and innate immune activation is influenced by donor age and sex | Kipkeu BJ, Almizraq R, Branch DR, Acker JP, Holovati JL | 2018 | ISBT Sci Ser | View Red cell supernatant effects on endothelial cell function and innate immune activation is influenced by donor age and sex | Researchers | Basic research |
ResearchUnit: Platelet protein GPIba plays an important role in regulating platelet-mediated production of thrombopoietin by the liver | Ni H | 2018 | Blood.ca website | View ResearchUnit: Platelet protein GPIba plays an important role in regulating platelet-mediated production of thrombopoietin by the liver | Other | Other |
Troubles de l'hémostase et angioedéme héréditaire | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Troubles de l'hémostase et angioedéme héréditaire | Health care providers | Other |
Window to the Unknown: Using Storytelling to Identify Learning Needs for the Intrinsic Competencies Within an Online Needs Assessment | Tseng EK, Jo D, Shih AW, De Wit K, Chan TM | 2018 | AEM Educ Train | View Window to the Unknown: Using Storytelling to Identify Learning Needs for the Intrinsic Competencies Within an Online Needs Assessment | Researchers | Education research |
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis | Branch DR, Hellberg Å, Bruggeman CW, Storry JR, Sakac D, Blacquiere M, Tong TN, Burke-Murphy E, Binnington B, Parmar N, Riden LS, Willie K, Armali C, Aziz J, Lieberman L, Laroche V, Callum J, Lin Y, Shehata N, Pavenski K, Lau W, Hannach B, Kuijpers TW, Olsson ML, Cserti-Gazdewich C, Pendergrast J | 2018 | Blood | View ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis | Health care providers | Clinical research |
Concentré de recherche: Un modèle de changement : prédiction de l'impact d'améliorations à l'échelle du système | Blake J | 2018 | Blood.ca website | View Concentré de recherche: Un modèle de changement : prédiction de l'impact d'améliorations à l'échelle du système | Researchers | Basic research |
Fetal and neonatal alloimmune thrombocytopenia: Novel mechanisms of miscarriage learned from placental pathology in animal models | Yougbare I, Zdravic D, Ni H | 2018 | J Pediatr Pediatr Med | View Fetal and neonatal alloimmune thrombocytopenia: Novel mechanisms of miscarriage learned from placental pathology in animal models | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Health care providers | New or improved product or process |
Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use | Lin Y, Cohen R, Armali C, Callum J, Cserti-Gazdewich C, Lieberman L, Pendergrast J | 2018 | Vox Sang | View Transfusion-associated circulatory overload prevention: a retrospective observational study of diuretic use | Researchers | Clinical research |
Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Almizraq RJ, Norris PJ, Inglis H, Menocha S, Wirtz MR, Juffermans N, Pandey S, Spinella PC, Acker JP, Muszynski JA | 2018 | Blood Adv | View Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity of red blood cell products and charactersitics of extracellular vesicles. | Researchers | Basic research |
Albumin | Clarke G, Yan M | 2018 | Clinical Guide to Transfusion | View Albumin | Health care providers | Other |
McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A | 2018 | J Thromb Haemost | View McMaster RARE-Best practices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome | Health care providers | Benchmarking and standard setting |
Designing the blood supply chain: how much, how and where? | Osorio AF, Brailsford SC, Smith HK, Blake J | 2018 | Vox Sang | View Designing the blood supply chain: how much, how and where? | Other | New or improved product or process |
Development of antifouling and bactericidal coatings for platelet storage bags using dopamine chemistry | Hadjesfandiari N, Weinhart M, Kizhakkedathu JN, Haag R, Brooks DE | 2018 | Adv Healthc Mater | View Development of antifouling and bactericidal coatings for platelet storage bags using dopamine chemistry | Researchers | New or improved product or process |
Label-free assessment of red blood cell storage lesions by deep learning | Doan M, Sebastian JA, Pinto PN, McQuin C, Goodman A, Wolkenhauer O, Parsons MJ, Acker JP, Rees P, Hennig H, Kolios MC, Carpenter AE | 2018 | bioRxiv | View Label-free assessment of red blood cell storage lesions by deep learning | Researchers | New or improved product or process |
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Feldman BM, Rivard GE, Babyn P, Wu JKM, Steele M, Poon M-C, Card RT, Israels SJ, Laferriere N, Gill K, Chan AK, Carcao M, Klaassen RJ, Cloutier S, Price VE, Dover S, Blanchette VS | 2018 | Lancet Haematol | View Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort | Health care providers | Clinical research |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | McEneny-King A, Chelle P, Iorio A, Edginton AN | 2018 | Thromb Res | View The effect of unmeasurable endogenous plasma factor activity levels on factor VIII dosing in patients with severe hemophilia A | Health care providers | Clinical research |
A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting | Sirianni G, Perri G, Callum J, Gardner S, Berall A, Selby D | 2018 | Am J Hosp Palliat Care | View A Retrospective Chart Review of Transfusion Practices in the Palliative Care Unit Setting | Researchers | Clinical research |
Signalement des réactions transfusionnelles indésirables | Chargé S, Young D | 2018 | Blood.ca website | View Signalement des réactions transfusionnelles indésirables | Health care providers | Other |
Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay | Kipkeu BJ, Shyian ML, da Silveira Cavalcante L, Duong TT, Yeung RSM, Binnington B, Branch DR, Acker JP, Holovati JL | 2018 | Transfusion | View Evaluation of the functional properties of cryopreserved buffy coat-derived monocytes for monocyte monolayer assay | Researchers | Basic research |
Concentré de recherche: Important rôle de la GPIba, une protéine plaquettaire, dans la régulation de la production hépatique de thrombopoiétine | Ni H | 2018 | Blood.ca website | View Concentré de recherche: Important rôle de la GPIba, une protéine plaquettaire, dans la régulation de la production hépatique de thrombopoiétine | Other | Other |
Concentrates for Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Concentrates for Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) | Turley E, McGowan EC, Hyland CA, Schoeman EM, Flower RL, Skoll A, Delisle MF, Nelson T, Clarke G, Au N | 2018 | Transfusion | View Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31) | Researchers | Clinical research |
Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Xu XR, Yousef GM, Ni H | 2018 | Blood | View Cancer and platelet crosstalk: opportunities and challenges for aspirin and other anti-platelet agents | Researchers | Basic research |
Concentré de recherche: Vers une uniformisation des politiques d'exclusion du don de sang et de plasma | Goldman M, O'Brien S, Devine D | 2018 | Blood.ca website | View Concentré de recherche: Vers une uniformisation des politiques d'exclusion du don de sang et de plasma | Researchers | Basic research |
Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Cohen R, Ning S, Yan MTS, Callum J | 2018 | Transfus Med Rev | View Transfusion Safety: The Nature and Outcomes of Errors in Patient Registration | Health care providers | Clinical research |
Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Iorio A, Edginton AN, Blanchette V, Blatny J, Boban A, Cnossen M, Collins P, Croteau SE, Fischer K, Hart DP, Ito S, Korth-Bradley J, Lethagen S, Lillicrap D, Makris M, Mathôt R, Morfini M, Neufeld EJ, Spears J | 2018 | Res Pract Thromb Haem | View Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Health care providers | Clinical research |
Hommes gais et don de sang : Un projet à l'étude | Otis J, Caruso J | 2018 | Fugues | View Hommes gais et don de sang : Un projet à l'étude | Other | Other |
Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay | Warkentin TE, Arnold DM, Kelton JG, Sheppard J-AI, Smith JW, Nazy I | 2018 | Chest | View Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay | Researchers | Basic research |